Which has grown faster, MRNA or ZTS?

Over the past five years, ZTS grew revenue faster — MRNA at a -2.60% CAGR versus ZTS at 6.28%.

Does MRNA or ZTS pay a bigger dividend?

ZTS pays a dividend (2.67% yield) while MRNA does not currently pay one.

Is MRNA or ZTS more profitable?

ZTS runs the higher net margin — MRNA at -143.55% versus ZTS at 27.79%.

Which has been the better investment, MRNA or ZTS?

Over the past 5-year, ZTS delivered the higher annualized total return — MRNA at -21.13% versus ZTS at 6.10%. Past performance doesn't predict future results.

Moderna, Inc. (MRNA) vs Zoetis Inc. (ZTS)

ZTS leads on 8 of 10 compared metrics.

A side-by-side comparison of Moderna, Inc. and Zoetis Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 18, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — MRNA vs ZTS

growth of $100 · last 8y

MRNA +232.3%ZTS -12.3%MRNA compounded faster

MRNA ZTS

MRNA vs ZTS: by the numbers

•ZTS is the larger company ($32.39B vs $24.52B market cap).
•ZTS is profitable (27.79% net margin) while MRNA runs a net loss (-143.55%).
•ZTS grew revenue faster over the past five years (6.28% vs -2.60% CAGR).
•ZTS pays a dividend (2.67% yield) while MRNA does not currently pay one.

Which is better, MRNA or ZTS?

Metric tally: MRNA 2 · ZTS 8

It depends on what you're optimizing for:

GrowthZTS(faster 5Y revenue CAGR)

QualityZTS(higher ROIC)

Metrics side by side

Valuation

Metric	MRNA	ZTS
P/E ratio	—	12.81
Forward P/E	—	10.44
P/S ratio	10.97	3.43●
P/B ratio	3.30●	10.10
PEG ratio	—	2.04
EV / EBITDA	—	9.91
FCF yield	—	6.54%

Profitability

Metric	MRNA	ZTS
Gross margin	-13.89%	70.75%●
Operating margin	-153.35%	37.57%●
Net margin	-143.55%	27.79%●
ROE	-43.12%	81.75%●
ROIC	-29.70%	21.54%●

Dividends

Metric	MRNA	ZTS
Dividend yield	—	2.67%
Payout ratio	—	34.16%

Growth (annualized)

Metric	MRNA	ZTS
Revenue CAGR (5Y)	-2.60%	6.28%●
EPS CAGR (5Y)	—	11.88%
FCF CAGR (5Y)	126.92%●	4.90%
Total return CAGR (5Y)	-21.13%	-15.30%●

Frequently asked

Which is better, MRNA or ZTS?: It depends on your goal. growth: ZTS (faster 5Y revenue CAGR); quality: ZTS (higher ROIC). Across all compared metrics, ZTS leads 8 to 2.
Which has grown faster, MRNA or ZTS?: Over the past five years, ZTS grew revenue faster — MRNA at a -2.60% CAGR versus ZTS at 6.28%.
Does MRNA or ZTS pay a bigger dividend?: ZTS pays a dividend (2.67% yield) while MRNA does not currently pay one.
Is MRNA or ZTS more profitable?: ZTS runs the higher net margin — MRNA at -143.55% versus ZTS at 27.79%.
Which has been the better investment, MRNA or ZTS?: Over the past 5-year, ZTS delivered the higher annualized total return — MRNA at -21.13% versus ZTS at 6.10%. Past performance doesn't predict future results.

Go deeper

Full MRNA analysis Full ZTS analysis Interactive comparison tool

Dig into the metrics

Moderna P/E ratio Zoetis P/E ratio Moderna dividend yield Zoetis dividend yield Moderna ROE Zoetis ROE Moderna operating margin Zoetis operating margin Moderna revenue growth Zoetis revenue growth Moderna free cash flow Zoetis free cash flow

Moderna & Zoetis appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 18, 2026.